CEO Herberg: "This Acquisition Strengthens our Position in the Important
Field of Pharmaceutics and Life-Science"
Closure of the Deal Expected Before the End of March
DUSSELDORF, Germany, March 26 /CNW/ - The Gerresheimer Group in
Dusseldorf has agreed to acquire the pharma-glass operations of the US company
Comar Inc. in Vineland (New Jersey). Closure of the deal is to take place at
the end of March.
Gerresheimer thereby consistently continues its expansion in the target
market of pharma/life-science. In this highly specialised market, Gerresheimer
ranks among the leading international suppliers of both glass and plastic
products. Comar uses tubular glass to produce high-quality pharmaceutical
vials and system components for pharmaceutics, diagnostics and analytical
Gerresheimer is one of the leading manufacturers of pharma glass in the
US and over a number of years has pushed ahead to achieve further business
expansion through targeted acquisitions in this attractive market.
Gerresheimer now has eight production plants in North America to supply the
dynamic pharma/life-science business. "With highly-developed production
technologies and an outstanding product range, the Glass Division of Comar
ideally complements the Gerresheimer product portfolio," says Dr. Axel
Herberg, President and CEO of the Gerresheimer Group.
The Comar Glass Division has been firmly established in the American
market for almost sixty years. With around 200 employees, up-to-date
technologies and a top-quality product range, the company is highly regarded
by its customers. The product range of the pharma-glass and diagnostics
business taken over by Gerresheimer comprises a wide variety of pharmaceutical
vials and sophisticated glass components for diagnostic and analytical
systems. Comar sales in the pharma glass sector totalled around US$24m in
This acquisition once again highlights Gerresheimer's dynamic development
in the global high-growth target markets across the pharma/life-sciences
sector. Just at the beginning of this year the Group purchased Wilden AG,
thereby advancing to become one of the leading European suppliers of
plastic-based pharmaceutical systems. In 2006 Gerresheimer also focussed on
entry into the Chinese market: through numerous acquisitions in this
fast-growing market region Gerresheimer secured a leading role as a supplier
of products for the pharma/life-science sector. "Many of our customers are
global players," Herberg explains. "Already today we can also supply them
globally thanks to our worldwide facilities structure."
Gerresheimer currently has 32 production plants in Europe, America and
Asia with 8,500 employees, and achieves sales of almost a billion euros.
Note to Editors:
You can request photos on this topic via our homepage. If required, we
can also send you high-resolution data. Reprint free of charge.
Please send specimen copy to Gerresheimer.
(c) Gerresheimer Group GmbH
Gerresheimer is a pharmaceutical & life-science supply and services
company with market leading positions of specialty products made of glass and
plastic. Gerresheimer owns 32 production sites in Europe, North America and
Asia and employs approximately 8,500 employees worldwide.
For further information:
For further information: Burkhard Lingenberg, Director Corporate PR &
Marketing, Telephone +49-(0)211-61-81-251, Telefax +49-(0)211-61-81-241,